SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-034308
Filing Date
2020-07-29
Accepted
2020-07-29 16:35:01
Documents
15
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20200729.htm   iXBRL 8-K 37914
2 EX-99.1 vktx-ex991_15.htm EX-99.1 300730
3 GRAPHIC gdtxvtzd5tk0000001.jpg GRAPHIC 4765
  Complete submission text file 0001564590-20-034308.txt   533726

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vktx-20200729.xsd EX-101.SCH 6310
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20200729_def.xml EX-101.DEF 14963
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20200729_lab.xml EX-101.LAB 25088
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20200729_pre.xml EX-101.PRE 15766
8 EXTRACTED XBRL INSTANCE DOCUMENT vktx-8k_20200729_htm.xml XML 5709
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 201057600
SIC: 2834 Pharmaceutical Preparations